June 25, 2025

drug-resistant tuberculosis

In this photo taken on January 18, 2024, Dr. Irene Flores, Clinical Head for the BPaL regimen for the drug resistant tuberculosis, shows the medicines for the BPaL regimen at a hospital in San Fernando, Pampanga. A faster and vastly more effective treatment for drug-resistant tuberculosis is being rolled out in the Asia-Pacific region, raising hopes of a "new era" in tackling one of the world's deadliest infectious diseases. (Photo by JAM STA ROSA / AFP)

New Treatment Offers Hope in Combatting Drug-Resistant TB in the Asia-Pacific Region

Jefferson028 mins

Learn more about the new treatment for drug-resistant TB in the Asia-Pacific region, offering hope for patients suffering from this deadly infectious disease. Trials have shown a cure rate of over 90% after just six months, providing a potential breakthrough in TB treatment. Read more about the impact of this new drug regimen and the experiences of patients like Efifanio Brillante.

Read More